Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1998 Feb;106(Suppl 1):57–69. doi: 10.1289/ehp.98106s157

Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.

S Yamamoto 1, K Urano 1, H Koizumi 1, S Wakana 1, K Hioki 1, K Mitsumori 1, Y Kurokawa 1, Y Hayashi 1, T Nomura 1
PMCID: PMC1533281  PMID: 9539005

Abstract

Carcinogenicity testing is indispensable for identifying environmental carcinogens and for evaluating the safety of drugs in the process of development. Conventional 2-year rodent bioassays are one of the most resource-consuming tests in terms of animals, time, and costs. Development of rapid carcinogenicity testing systems that can assess carcinogenicity within a short period has become a social demand and is essential to improve efficacy in the identification of environmental carcinogens as well as in the development of new drugs. In this review we introduce the rapid carcinogenicity testing system using transgenic (Tg) mice carrying the human prototype c-Ha-ras gene, namely rasH2 mouse (CB6F1-TgHras2 mouse is the same mouse). The studies have been conducted to validate the rasH2 mouse as a model for the rapid carcinogenicity testing system. Our current validation studies revealed that rasH2 mice are able to detect various types of mutagenic carcinogens within 6 months. The rasH2 mice may also be able to detect various nonmutagenic carcinogens. The validation studies also revealed that rasH2 mice are generally much more susceptible to both mutagenic and nonmutagenic carcinogens than control non-Tg mice. No significant tumor induction has been observed in rasH2 mice with either mutagenic or nonmutagenic noncarcinogens. More rapid onset and higher incidence of more malignant tumors can be expected with a high probability after treatment with various carcinogens in the rasH2 mice than in control non-Tg mice. The rasH2 mouse appears to be a promising candidate as an animal model for development of a rapid carcinogenicity testing system.

Full text

PDF
57

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson M. W., Reynolds S. H., You M., Maronpot R. M. Role of proto-oncogene activation in carcinogenesis. Environ Health Perspect. 1992 Nov;98:13–24. doi: 10.1289/ehp.929813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ando K., Saitoh A., Hino O., Takahashi R., Kimura M., Katsuki M. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes. Cancer Res. 1992 Feb 15;52(4):978–982. [PubMed] [Google Scholar]
  3. Ashby J., Tennant R. W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat Res. 1991 May;257(3):229–306. doi: 10.1016/0165-1110(91)90003-e. [DOI] [PubMed] [Google Scholar]
  4. Belinsky S. A., Devereux T. R., Foley J. F., Maronpot R. R., Anderson M. W. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res. 1992 Jun 1;52(11):3164–3173. [PubMed] [Google Scholar]
  5. Bos J. L. ras oncogenes in human cancer: a review. Cancer Res. 1989 Sep 1;49(17):4682–4689. [PubMed] [Google Scholar]
  6. Chen B., Johanson L., Wiest J. S., Anderson M. W., You M. The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1589–1593. doi: 10.1073/pnas.91.4.1589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Deschner E. E., Hakissian M., Long F. C. Genetic factors controlling inheritance of susceptibility to 1,2-dimethylhydrazine. J Cancer Res Clin Oncol. 1989;115(4):335–339. doi: 10.1007/BF00400959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Diwan B. A., Rice J. M., Ohshima M., Ward J. M. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice. Carcinogenesis. 1986 Feb;7(2):215–220. doi: 10.1093/carcin/7.2.215. [DOI] [PubMed] [Google Scholar]
  9. Dragani T. A., Manenti G., Della Porta G. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res. 1991 Dec 1;51(23 Pt 1):6299–6303. [PubMed] [Google Scholar]
  10. Grasso P., Sharratt M., Cohen A. J. Role of persistent, non-genotoxic tissue damage in rodent cancer and relevance to humans. Annu Rev Pharmacol Toxicol. 1991;31:253–287. doi: 10.1146/annurev.pa.31.040191.001345. [DOI] [PubMed] [Google Scholar]
  11. Guerrero I., Pellicer A. Mutational activation of oncogenes in animal model systems of carcinogenesis. Mutat Res. 1987 May;185(3):293–308. doi: 10.1016/0165-1110(87)90021-2. [DOI] [PubMed] [Google Scholar]
  12. Hawkins B. L., Heniford B. W., Ackermann D. M., Leonberger M., Martinez S. A., Hendler F. J. 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma. Head Neck. 1994 Sep-Oct;16(5):424–432. doi: 10.1002/hed.2880160506. [DOI] [PubMed] [Google Scholar]
  13. Hoffmann D., Rivenson A., Chung F. L., Hecht S. S. Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis. Crit Rev Toxicol. 1991;21(4):305–311. doi: 10.3109/10408449109017917. [DOI] [PubMed] [Google Scholar]
  14. Inayama Y. Promoting action of glycerol in pulmonary tumorigenesis model using a single administration of 4-nitroquinoline 1-oxide in mice. Jpn J Cancer Res. 1986 Apr;77(4):345–350. [PubMed] [Google Scholar]
  15. Kumagai H., Kawaura A., Furuya K., Izumi K., Otsuka H. Perianal lesions of BALB/c mice induced by 1,2-dimethylhydrazine dihydrochloride and methylazoxymethanol-acetate: their classification and histogenesis. Gan. 1982 Jun;73(3):358–364. [PubMed] [Google Scholar]
  16. Lowy D. R., Willumsen B. M. Function and regulation of ras. Annu Rev Biochem. 1993;62:851–891. doi: 10.1146/annurev.bi.62.070193.004223. [DOI] [PubMed] [Google Scholar]
  17. Malkinson A. M. The genetic basis of susceptibility to lung tumors in mice. Toxicology. 1989 Mar;54(3):241–271. doi: 10.1016/0300-483x(89)90062-0. [DOI] [PubMed] [Google Scholar]
  18. Maronpot R. R., Fox T., Malarkey D. E., Goldsworthy T. L. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology. 1995 Aug 25;101(3):125–156. doi: 10.1016/0300-483x(95)03112-s. [DOI] [PubMed] [Google Scholar]
  19. Massey T. E., Devereux T. R., Maronpot R. R., Foley J. F., Anderson M. W. High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57BL/6J x BALB/cJ) mice. Carcinogenesis. 1995 May;16(5):1065–1069. doi: 10.1093/carcin/16.5.1065. [DOI] [PubMed] [Google Scholar]
  20. Massey T. E., Devereux T. R., Maronpot R. R., Foley J. F., Anderson M. W. High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57BL/6J x BALB/cJ) mice. Carcinogenesis. 1995 May;16(5):1065–1069. doi: 10.1093/carcin/16.5.1065. [DOI] [PubMed] [Google Scholar]
  21. Mitsumori K., Wakana S., Yamamoto S., Kodama Y., Yasuhara K., Nomura T., Hayashi Y., Maronpot R. R. Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors. Mol Carcinog. 1997 Nov;20(3):298–307. doi: 10.1002/(sici)1098-2744(199711)20:3<298::aid-mc6>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  22. NAKAHARA W., FUKUOKA F., SUGIMURA T. Carcinogenic action of 4-nitroquinoline-N-oxide. Gan. 1957 Jun;48(2):129–137. [PubMed] [Google Scholar]
  23. Nakae D., Andoh N., Mizumoto Y., Endoh T., Shimoji N., Horiguchi K., Shiraiwa K., Tamura K., Denda A., Konishi Y. Selective 8-hydroxyguanine formation in pancreatic DNA due to a single intravenous administration of 4-hydroxyaminoquinoline 1-oxide in rats. Cancer Lett. 1994 Aug 15;83(1-2):97–103. doi: 10.1016/0304-3835(94)90304-2. [DOI] [PubMed] [Google Scholar]
  24. Nakanishi K., Kurata Y., Oshima M., Fukushima S., Ito N. Carcinogenicity of phenacetin: long-term feeding study in B6c3f1 mice. Int J Cancer. 1982 Apr 15;29(4):439–444. doi: 10.1002/ijc.2910290413. [DOI] [PubMed] [Google Scholar]
  25. Rao M. S., Subbarao V., Scarpelli D. G. Atypical acinar cell lesions of the pancreas in mice induced by 4-hydroxyaminoquinoline-1-oxide. Int J Pancreatol. 1987 Feb;2(1):1–10. doi: 10.1007/BF02788344. [DOI] [PubMed] [Google Scholar]
  26. Reddy B. S., Maeura Y. Dose-response studies of the effect of dietary butylated hydroxyanisole on colon carcinogenesis induced by methylazoxymethanol acetate in female CF1 mice. J Natl Cancer Inst. 1984 May;72(5):1181–1187. [PubMed] [Google Scholar]
  27. Saitoh A., Kimura M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., Katsuki M. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene. 1990 Aug;5(8):1195–1200. [PubMed] [Google Scholar]
  28. Spalding J. W., Momma J., Elwell M. R., Tennant R. W. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene. Carcinogenesis. 1993 Jul;14(7):1335–1341. doi: 10.1093/carcin/14.7.1335. [DOI] [PubMed] [Google Scholar]
  29. Stanley L. A., Devereux T. R., Foley J., Lord P. G., Maronpot R. R., Orton T. C., Anderson M. W. Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice. Carcinogenesis. 1992 Dec;13(12):2427–2433. doi: 10.1093/carcin/13.12.2427. [DOI] [PubMed] [Google Scholar]
  30. Storer R. D., Cartwright M. E., Cook W. O., Soper K. A., Nichols W. W. Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice. Carcinogenesis. 1995 Feb;16(2):285–293. doi: 10.1093/carcin/16.2.285. [DOI] [PubMed] [Google Scholar]
  31. Tennant R. W., French J. E., Spalding J. W. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ Health Perspect. 1995 Oct;103(10):942–950. doi: 10.1289/ehp.95103942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tennant R. W., Spalding J., Stasiewicz S., Ashby J. Prediction of the outcome of rodent carcinogenicity bioassays currently being conducted on 44 chemicals by the National Toxicology Program. Mutagenesis. 1990 Jan;5(1):3–14. doi: 10.1093/mutage/5.1.3. [DOI] [PubMed] [Google Scholar]
  33. Tennant R. W. Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard. Mutat Res. 1993 Mar;286(1):111–118. doi: 10.1016/0027-5107(93)90006-2. [DOI] [PubMed] [Google Scholar]
  34. Thurnherr N., Deschner E. E., Stonehill E. H., Lipkin M. Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine. Cancer Res. 1973 May;33(5):940–945. [PubMed] [Google Scholar]
  35. Yamamoto S., Hayashi Y., Mitsumori K., Nomura T. Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene. Lab Anim Sci. 1997 Apr;47(2):121–126. [PubMed] [Google Scholar]
  36. Yamamoto S., Mitsumori K., Kodama Y., Matsunuma N., Manabe S., Okamiya H., Suzuki H., Fukuda T., Sakamaki Y., Sunaga M. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. Carcinogenesis. 1996 Nov;17(11):2455–2461. doi: 10.1093/carcin/17.11.2455. [DOI] [PubMed] [Google Scholar]
  37. You M., Wang Y., Stoner G., You L., Maronpot R., Reynolds S. H., Anderson M. Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5804–5808. doi: 10.1073/pnas.89.13.5804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zeiger E., Haseman J. K., Shelby M. D., Margolin B. H., Tennant R. W. Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals. Environ Mol Mutagen. 1990;16 (Suppl 18):1–14. doi: 10.1002/em.2850160502. [DOI] [PubMed] [Google Scholar]
  39. de Vries A., van Oostrom C. T., Hofhuis F. M., Dortant P. M., Berg R. J., de Gruijl F. R., Wester P. W., van Kreijl C. F., Capel P. J., van Steeg H. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature. 1995 Sep 14;377(6545):169–173. doi: 10.1038/377169a0. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of American Chemical Society

RESOURCES